Literature DB >> 28728183

Early Focal Laser Photocoagulation in Acute Central Serous Chorioretinopathy: A Prospective, Randomized Study.

Vikas Ambiya, Mitali Khodani, Abhilash Goud, Raja Narayanan, Mudit Tyagi, Padmaja Kumari Rani, Jay Chhablani.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the role of early focal laser photocoagulation in acute central serous chorioretinopathy (CSC). PATIENTS AND METHODS: A total of 58 eyes with acute naïve CSC (less than 2 months' duration) with focal leak on fundus fluorescein angiography (FFA) were randomized into either a laser or a sham laser group. Eyes with chronic CSC and subfoveal leak were excluded. Visual acuity assessment, microperimetry, optical coherence tomography, and FFA were done at baseline, 1 month (minus FFA), 3 months, and 6 months after treatment.
RESULTS: There was a significant improvement in best-corrected visual acuity, low-contrast visual acuity, retinal sensitivity, and central macular thickness at all visits in both groups (P < .001); however, there was no significant difference between the groups regarding time of resolution. Four eyes in the sham laser group needed rescue laser compared with one eye in early laser group (P = .16).
CONCLUSION: Early laser photocoagulation is not superior to sham laser for acute CSC; therefore, observation appears to the safest and most effective strategy. [Ophthalmic Surg Lasers Imaging Retina. 2017;48:564-571.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Year:  2017        PMID: 28728183     DOI: 10.3928/23258160-20170630-07

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  7 in total

1.  Multifocal electroretinography-assisted anatomical and functional evaluation of subthreshold green laser in acute central serous chorioretinopathy.

Authors:  Neha Goel; Aanchal Mehta; A K Gupta
Journal:  Indian J Ophthalmol       Date:  2021-09       Impact factor: 1.848

2.  577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study.

Authors:  He Long; Maoxiong Liu; Qinghua Hu; Xin Li
Journal:  BMC Ophthalmol       Date:  2022-03-05       Impact factor: 2.209

3.  Change in choroidal vascularity in acute central serous chorioretinopathy.

Authors:  Mohammed Abdul Rasheed; Abhilash Goud; Ashik Mohamed; Kiran Kumar Vupparaboina; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848

4.  Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium.

Authors:  Hakan Kaymak; Saskia Funk; Andreas Fricke; Roxana Fulga; Karsten Klabe; Berthold Seitz; Achim Langenbucher; Hartmut Schwahn
Journal:  Int J Retina Vitreous       Date:  2020-06-04

Review 5.  Management of chronic central serous chorioretinopathy.

Authors:  Daren Hanumunthadu; Anna C S Tan; Sumit Randhir Singh; Niroj Kumar Sahu; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

6.  Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset.

Authors:  Maciej Gawęcki; Agnieszka Jaszczuk-Maciejewska; Anna Jurska-Jaśko; Małgorzata Kneba; Andrzej Grzybowski
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

7.  Short-Term Outcomes of Cataract Surgery in Patients with a History of Central Serous Chorioretinopathy.

Authors:  Jeon Young Joon; Jae Hui Kim; Jong Woo Kim; Chul Gu Kim
Journal:  J Ophthalmol       Date:  2021-06-24       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.